GSK-MY-1037/BRL-029060/1/CPMS-136

Study Sponsor: GSK

Study Title

A Double-Blind Study to Assess the Efficacy and Tolerance of a Flexible Dose of Paroxetine Compared with a Flexible Dose of Clomipramine and Placebo in the Treatment of Obsessive Compulsive Disorder.

Medicine or Vaccine (generic name)

paroxetine

Sponsor Identification Number

MY-1037/BRL-029060/1/CPMS-136

Trial Registry Identification Number(#'s)

Medical Condition

Obsessive-Compulsive Disorder

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=29060/136

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study. An annotated case report form, a reporting and analysis plan, a clinical study report, and a protocol are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.

Date Added to this Site

December 2014